Secondary cancers, Womb (uterine or endometrial) cancer
Open
Phase 3
This trial is comparing trastuzumab pamirtecan with chemotherapy for womb cancer.
It is for women whose cancer:
has come back or grown after previous treatment
has low to high amounts of the
You pronounce trastuzumab pamirtecan as tras-too-zoo-mab pam-ir-tee-can
Recruitment start: 10 September 2025
Recruitment end: 31 May 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr John McGrane
BioNTech SE
Last reviewed: 06 Mar 2026
CRUK internal database number: 20122
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
